Dr. Paul F. Walsh, MD

Dr. Walsh practices at Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health.

Dr. Walsh's NPI, 1578529947, was assigned on April 25, 2006. Dr. Walsh graduated from University College of Dublin National Univ SOM in 1994. Dr. Walsh holds California license A63330.

Dr. Walsh's primary practice is Sutter Medical Center, Sacramento, at 2825 Capitol Avenue, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 454-2222.

Dr. Walsh's primary practice is Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health. The medical group on file is Vituity. Dmand AI also links Dr. Walsh to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Walsh practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Walsh's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Walsh is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Walsh is licensed in California.

CMS data shows 56 Medicare services from Dr. Walsh across 3 procedure codes in 2024, for 50 Medicare patients. Medicare paid $4,892 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Dr. Walsh in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Walsh's median patient age at 12, with 48% women.

In 2024, Dr. Walsh wrote 37 Medicare Part D claims for 23 patients. 92% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $109 in total drug cost. In 2016, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Walsh for performance year 2024, reported as part of a group. Dr. Walsh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 47 papers to Dr. Walsh, published from 2011 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Bronchiolitis, Cattle and Emergency Service, Hospital. Dr. Walsh has published most often in PLoS One. Dr. Walsh's most frequent co-authors are Sabrina Merchant, MD, Dale R. Robbins, MD and Lucas Shanholtzer, MD.

Dmand AI links Dr. Walsh to 1 clinical trial. Conditions studied include Bronchiolitis and Bronchitis.

CMS Open Payments shows 2 general payments to Dr. Walsh from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 69% of the total. Novartis Pharmaceuticals Corporation paid the most, $85.

Dr. Walsh graduated from University College of Dublin National Univ SOM in 1994.

Dr. Walsh is in network with 2 carriers, including CMS Medicare and NV State Medicaid. Medicaid plans come from the most carriers, 1. Check the plan with the practice before a visit.